Coagulation indicators in patients with paroxysmal atrial fibrillation: Effects of electric and pharmacologic cardioversion

被引:33
|
作者
Giansante, C
Fiotti, N
Miccio, M
Altamura, N
Salvi, R
Guarnieri, G
机构
[1] Univ Trieste, Inst Clin Med, I-34149 Trieste, Italy
[2] Osped Maggiore, Emergency Unit, Trieste, Italy
关键词
D O I
10.1067/mhj.2000.108520
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to determine whether paroxysmal atrial fibrillation (PAF) and/or restoration to sinus rhythm with electric or pharmacologic cardioversion induce modifications to the coagulation system. Thirty-five patients with PAF undergoing either electric (n = 11) or pharmacologic (n = 24) cardioversion were studied. Fibrinopeptide A and D-dimer blood samples were taken immediately before and after cardioversion at different intervals. When compared with the control group (n = 70), the precardioversion fibrinopeptide A plasma values were significantly elevated (11.8 vs 2.5 ng/ml). Fibrinopeptide A plasma values were significantly reduced 5 minutes after cardioversion (11.8 vs 5.3 ng/mL) and remained stable throughout the follow-up sequential measurements. D-dimer plasma values were significantly increased (measured at 12 hours and at day 7) in patients who underwent electrical cardioversions only. A positive correlation (R-2 = 0.76) was found between the energy delivered for cardioversion to sinus rhythm and D-dimer plasma values on day 7. in patients with PAF, levels of fibrinopeptide A, an indicator of coagulation activation, are elevated and soon reduced by the restoration of sinus rhythm. Electric, but not pharmacologic, cardioversion induces an early activation of the fibrinolytic system.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 50 条
  • [41] The effectiveness of oral flecainide and propafenone in the cardioversion and prophylaxis of paroxysmal atrial fibrillation
    Navazio, A
    Modena, MG
    Chesi, G
    Catellani, E
    Montanari, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 51137 - 51137
  • [42] Impact of Electrode Size on the Efficacy of Electrical Cardioversion for Paroxysmal Atrial Fibrillation
    Vostrikov V.A.
    Razumov K.V.
    Gorbunov B.B.
    Biomedical Engineering, 2016, 50 (3) : 179 - 183
  • [43] Antazoline for pharmacologic cardioversion of atrial fibrillation: teaching an old drug new tricks
    Lip, Gregory Y. H.
    Mills, Mark T.
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2024, 134 (04):
  • [44] "Pill in the Pocket" Antiarrhythmic Drugs for Orally Administered Pharmacologic Cardioversion of Atrial Fibrillation
    Reiffel, James A.
    Capucci, Alessandro
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 140 : 55 - 61
  • [45] Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation
    Van Gelder, IC
    Tuinenburg, AE
    Schoonderwoerd, BS
    Tieleman, RG
    Crijns, HJGM
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (9A): : 147R - 151R
  • [46] ELECTRIC CARDIOVERSION VS PHARMACOLOGICAL THEN ELECTRIC CARDIOVERSION FOR NEW ONSET ATRIAL FIBRILLATION: A META-ANALYSIS
    Prasai, Paritosh
    Shrestha, Dhan
    Saad, Eltaib
    Trongtorsak, Angkawipa
    Adhikari, Aarya
    Gaire, Suman
    Adhikari, Pabitra
    Devkota, Amrit
    Oli, Prakash Raj
    Shtembari, Jurgen
    Sedhai, Yub Raj
    Akbar, Muhammad Sikander
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 175 - 175
  • [47] ELECTROPHYSIOLOGICAL EFFECTS OF MEXILETINE ON ATRIAL VULNERABILITY IN PATIENTS WITH PAROXYSMAL ATRIAL-FIBRILLATION
    OMORI, I
    FURUKAWA, K
    INOUE, D
    ASAYAMA, J
    KATSUME, H
    NAKAGAWA, M
    CLINICAL DRUG INVESTIGATION, 1995, 9 (05) : 298 - 302
  • [48] Hemodynamic effects of alternative atrial pacing sites in patients with paroxysmal atrial fibrillation
    Dabrowska-Kugacka, A
    Lewicka-Nowak, E
    Kutarski, A
    Zagozdon, P
    Swiatecka, G
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (01): : 278 - 283
  • [49] Optimal timing for cardioversion in patients with atrial fibrillation
    Hellman, Tapio
    Kiviniemi, Tuomas
    Nuotio, Ilpo
    Biancari, Fausto
    Vasankari, Tuija
    Hartikainen, Juha
    Lehto, Mika
    Airaksinen, K. E.
    CLINICAL CARDIOLOGY, 2018, 41 (07) : 966 - 971
  • [50] Safety of electrical cardioversion in patients with atrial fibrillation
    Gentile, F
    Elhendy, A
    Khandheria, BK
    Seward, JB
    Lohse, CM
    Shen, WK
    Bailey, KR
    Montgomery, SC
    Burger, KN
    Tajik, AJ
    MAYO CLINIC PROCEEDINGS, 2002, 77 (09) : 897 - 904